Crossmark

Safety of talimogene laherparepvec: a real‐world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS)

Published Online: 2024-12-18

Authors

Hong, Yifan https://orcid.org/0009-0007-6079-5895
Cheng, Kebin https://orcid.org/0000-0002-2617-9702
Qu, Han

Wang, Yuting

Wang, Yuanyuan

Fan, Guorong

Wu, Zhenghua https://orcid.org/0000-0001-8639-9689
License Information

Text and Data Mining valid from 2024-12-18

Version of Record valid from 2024-12-18
More Information

Article History

Received: 16 July 2024

Accepted: 17 October 2024

First Online: 18 December 2024

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

Document is current